News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DxS Ltd Collaborates with AstraZeneca AB to Provide a Companion Diagnostic for IRESSA(TM)



7/31/2009 1:40:54 PM

MANCHESTER, England--(BUSINESS WIRE)--DxS Ltd, a personalised medicine company and leaders in the provision of companion diagnostics, has announced it is working closely with AstraZeneca to make available a companion diagnostic for use with IRESSA™ (gefitinib), AstraZeneca’s treatment for non small cell lung cancer (NSCLC).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES